Preventice Solutions, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Preventice Solutions, Inc.
Value-based care, leveraging digital health and analytics, is now viewed as the all-important ingredient in sustainable health care delivery. With that in mind, Boston Scientific and global professional services company Accenture have recently joined forces in a total-cost-of-care heart failure project that is rewarded on patient outcomes.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced July-August 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2015.
The excitement about digital health solutions has reached new heights as the market moves toward changes where those solutions are not only wanted, but in many cases needed to help battle costs and improve patient outcomes. The interest in digital health is part of a larger trend that is seeing patients take on more and more responsibility for their own health amid changing perceptions of what is considered a medical device.
- Digital Health
- Monitoring Equipment & Devices
- Other Names / Subsidiaries
- eCardio Diagnostics
- Preventice, Inc.